A Phase 4 interventional study of Metal on Metal Hip System and Highly Cross Linked Polyethylene cup System in Osteoarthritis, Avascular Necrosis and Rheumatoid Arthritis, sponsored by Nova Scotia Health Authority. Terminated. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2015-05-15.
Sponsored by Nova Scotia Health Authority · Phase 4, Interventional, and Treatment
This trial will evaluate the 36mm or greater metal head on metal hip system and compare it to the 32mm or 28mm metal head on polyethylene (liner) hip system in patients receiving a primary cementless total hip replacement.
623 studies on the registry are indexed under Spondylitis; 83 are open to participants now.
This study's enrollment of 41 is below the median of 92 across 349 interventional studies indexed under Spondylitis.
Browse Spondylitis studies →Nova Scotia Health Authority is the lead sponsor of 255 studies on the registry; 76 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Metal on Metal articulation system
Device: Metal on Metal Hip System
THA using Highly Cross Linked Polyethylene cup System
Device: Highly Cross Linked Polyethylene cup System
Total hip arthroplasty with a metal on metal component system
Also known as: Depuy ASR
Total hip arthroplasty with Highly Cross Linked Polyethylene cup System
Also known as: Depuy Pinnacle Cup and Marathon liner
Revision Rate
Time frame: 4 years
Wear and osteolysis
Time frame: 5-15 years
Harris Hip Score
Time frame: immediate post-op, 6 months, 1 year, 2 years, 4 years
Dislocation Rate
Time frame: 4 years
Complication Rate
All complications
Time frame: 4 years
Gait Analysis
Using the Walkabout portable gait monitor
Time frame: 6 months and 1 year post-op
Metal Ions
Time frame: 4 years
No study locations are listed for this record.
This study is terminated, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nova Scotia Health Authority